Skip to main content

Table 3 Anthropometric measurements (PP) at different control times (T1 baseline and, T5, T9, T13) in groups treated with polyglucosamine and orlistat

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable

Group

T1a

T4a

T9a

T13a

Weight (kg)

polyglucosamine

100.9 ± 13.44

97.2 ± 12.61

95.4 ± 12.79

94.1 ± 13.41

orlistat

97.9 ± 11.55

95.1 ± 11.24

94.5 ± 11.98

93.1 ± 11.82

BMI (kg/m2)

polyglucosamine

34.6 ± 3.69

33.4 ± 3.58

32.8 ± 3.50

32.3 ± 3.59

orlistat

34.7 ± 4.76

33.7 ± 4.60

33.4 ± 4.68

33.0 ± 4.63

WC (cm)

polyglucosamine

113.4 ± 11.13

109.6 ± 12.10

107.4 ± 11.85

105.1 ± 11.98

orlistat

109.5 ± 10.13

106.8 ± 9.55

104.2 ± 9.30

103.4 ± 9.14

  1. aThe differences between groups are not statistically significant (t test)